Background
Management of breast ductal carcinoma in situ (DCIS) has various approaches with distinct institutional specific practice. Here, we review DCIS management in a single institution with emphasize on re‐operation rates and outcome.
Methods
Breast ductal carcinoma in situ cases diagnosed at the Nottingham Breast Institute between 1987 and 2017 were identified (n = 1249). Clinicopathological data were collected. Cases were histologically reviewed, and different factors associated with primary operation selection, re‐excision, presence of residual tumor in the re‐excision specimens, use of radiotherapy and ipsilateral recurrences were analyzed.
Results
34% of DCIS patients were initially treated by mastectomy and were more frequently symptomatic, of high nuclear tumor grade, size >40 mm, and associated with comedo necrosis and Paget's disease of the nipple. Further surgery was due to involved or narrow surgical margins. Residual tumor tissue was detected in 53% of the re‐excision specimens. Re‐excision rates of patients treated with breast‐conserving surgery (BCS) were reduced from approximately 70% to 23%, and the final mastectomy rates decreased from 60% to 20%. Changes in surgical practice with acceptance of smaller excision margins and more frequent use of local radiotherapy have led to a significant decrease not only in the re‐excision rate but also in the final mastectomy rate together with non‐significant reduction in 5‐ and 10‐year local recurrence rates.
Conclusion
Although BCS is increasingly the preferred primary surgical option for DCIS management, a proportion of low‐risk DCIS patients continue to undergo re‐excision surgery or completion mastectomy. Despite acceptance of smaller margins, recurrence rate is decreasing.